课题基金 / 基金详情

Universal vaccine approaches for current SARS-CoV-2 variants and future coronaviruses in LMICs

Universal vaccine approaches for current SARS-CoV-2 variants and future coronaviruses in LMICs
针对中低收入国家当前 SARS-CoV-2 变种和未来冠状病毒的通用疫苗方法
批准号:
450262
负责人:
Kelvin Alyson A
金额:
$14.2万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-07-01 至 2023-07-01

项目摘要

项目成果

Kelvin Alyson A的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The COVID-19 (coronavirus disease 2019) pandemic caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2 or SARS2) has significantly impacted global public health and wellbeing. Newly developed COVID-19 vaccines protect against infection o
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of coronavirus cross-reactivity and immune durability for pan-coronavirus vaccine development
  • 批准号:
    478959
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.04万
  • 财政年份:
    2023
  • 负责人:
    Kelvin Alyson A
  • 依托单位:
Investigation of Mpox virus spillover and spillback at the human-animal interface in the Democratic Republic of Congo
  • 批准号:
    481127
  • 项目类别:
    Operating Grants
  • 资助金额:
    $36.43万
  • 财政年份:
    2023
  • 负责人:
    Kelvin Alyson A
  • 依托单位:
Understanding mechanisms coronavirus cross-reactivity, immune durability, and pan-coronavirus vaccine protection
  • 批准号:
    473353
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Kelvin Alyson A
  • 依托单位:
Preclinical Models for Monkeypox Virus Infection and Therapeutic Development
  • 批准号:
    473337
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Kelvin Alyson A
  • 依托单位: